ACCLAIM: A Randomized Trial of Abatacept (CTLA4-Ig) for Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis - United States
doi 10.1177/1352458516662727
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy